Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01ELU
|
|||
| Former ID |
DIB001631
|
|||
| Drug Name |
VSN-16R
|
|||
| Synonyms |
VSN series (muscular spasm), Canbex Therapeutics; VSN-16R (muscular spasm); VSN-16R (muscular spasm), Canbex Therapeutics
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Muscle spasm [ICD-11: MB47.3; ICD-10: R25.2] | Phase 2 | [1] | |
| Company |
Canbex Therapeutics Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H26N2O3
|
|||
| Canonical SMILES |
CC(CO)NC(=O)C1=CC=CC(=C1)C=CCCCC(=O)N(C)C
|
|||
| InChI |
1S/C18H26N2O3/c1-14(13-21)19-18(23)16-10-7-9-15(12-16)8-5-4-6-11-17(22)20(2)3/h5,7-10,12,14,21H,4,6,11,13H2,1-3H3,(H,19,23)/b8-5-/t14-/m1/s1
|
|||
| InChIKey |
SVYRYFAUQHVGAI-BMWLXYDHSA-N
|
|||
| CAS Number |
CAS 1246960-09-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02542787) Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.